How urban hospitals can help rural pharmacies
April 17th 2006Virtually none of the more than 1,000 rural critical access hospitals (CAHs) in rural America can afford a round-the-clock R.Ph. on staff. And this lack of coverage can adversely affect quality by slowing the prescription review process, said Tim Stratton, R.Ph., Ph.D., an associate professor at the University of Minnesota College of Pharmacy in Duluth.
Preparing for the worst: Hospitals...
April 17th 2006In the aftermath of the Sept. 11 attacks, disaster preparedness became a priority for the nation's hospitals. Then interest in the topic trailed off somewhat. But in the late summer of 2005, Hurricanes Katrina and Rita slammed the Gulf Coast, and disaster preparedness was suddenly back with a vengeance.
Clinical Twisters: Surgery when INR=2.8
April 17th 2006An ambulatory 70-year-old man, F.H., has been admitted to yourhospital with a hip fracture that will require surgery. AlthoughF.H. has a history of atrial fibrillation (AF) episodes andtransient ischemic attacks (TIA), his heart is currently in normalsinus rhythm. Medications on admission included verapamil 120 mgand warfarin 5 mg daily; fracture pain is being treated withmorphine intramuscular (IM) injections at present. F.H.'s INR(International Normalized Ratio) on admission is 2.8; bloodpressure is 135/75; lab tests were within normal limits. F.H.'sphysician requests an anticoagulation consult to aid him indetermining the timing of surgery and venothromboembolism (VTE)prophylaxis. What do you suggest?
Work group striving to clarify Part D electronic messages
April 17th 2006There may be relief in sight for pharmacists frustrated with confusing and even contradictory electronic messages beamed their way by Part D insurance plans, thanks to a work group created by associations representing drugstore chains, independent pharmacy, and health insurance plans.
CMS reports improvements in Medicare Part D
April 17th 2006Things are looking up in relation to Medicare Part D, according to Mark McClellan, head of the Centers for Medicare & Medicaid Services. In early March, he addressed an audience of 700 pharmacists from New England on the status of the drug benefit, as the program passed its 60th day in operation. The presentation was the keynote address at the 66th Howard L. Reed Conference, sponsored by the Massachusetts College of Pharmacy and Health Sciences.
New drug delivery good for older drugs
April 17th 2006Innovative delivery of drugs that are already Food & Drug Administration-approved appears to be the way of the future. And, in many cases, the future is already here. While great strides have been made in the development of new drug entities, an often easier way for companies to maintain market share and compete with generics is to utilize newer delivery techniques with older drugs already proven effective. In many cases, the new developments will offer additional advantages such as ease of administration, fewer side effects, and increased patient compliance. Here are a few examples of products in the pipeline with unique formulations.
This shot targets those exposed to hepatitis B
April 17th 2006The Food & Drug Administration recently approved hepatitis B immune globulin [human] (HepaGam B, Cangene) for the treatment of acute exposure to blood containing hepatitis B surface antigens (HBsAg), perinatal exposure of infants born to HBsAg-positive mothers, sexual exposure to HBsAg-positive persons, and household exposure to those with acute hepatitis B virus (HBV) infection.
Part D protesters and MTM highlight APhA show
April 17th 2006Brandishing signs and chanting slogans, protesters gathered on the steps of the San Francisco convention center to urge the American Pharmacists Association to take a stand against the Medicare drug plan. Meanwhile, inside the convention hall, APhA conference attendees got the bad news that only 5% of Part D plans are using any community-based providers for medication therapy management (MTM) programs.
CVS offers seniors help to meet Part D deadline
April 10th 2006As the May 15 deadline approaches for Medicare Part D enrollment, CVS is continuing its efforts to educate and inform seniors about the new prescription drug benefit plan. Medicare Tuesdays returns to CVS pharmacies from April 11 to May 9, featuring a staff member who will answer questions and help patients review available drug benefit plans.
Reward out for information in Indiana pharmacy robberies
April 10th 2006Crime Stoppers of Central Indiana is offering up to $1,000 cash reward for information leading to the arrest of suspect(s) responsible for pharmacy robberies in the central Indiana area. The robberies occurred at a Kroger Pharmacy in Carmel, a CVS in Westfield, and a CVS in Zionsville.
Is Medicare paying too much for dialysis drugs?
April 10th 2006Independent dialysis facilities are getting paid by Medicare for darbepoetin alfa (Aranesp, Amgen) and other new end-stage renal disease drugs more than what they are paying to acquire them. That's the conclusion of a new report from the Office of Inspector General.
There will be fewer Part D plans to wade through next year
April 10th 2006Conceding that there are too many Part D prescription drug plans for Medicare beneficiaries to choose from now, HHS is limiting the number of PDPs insurers can offer from three per region this year to two next year. Insurers that offer enhanced coverage may have more leeway to offer three plans.
DVT prevention in hospitals is lacking
April 10th 2006Deep vein thrombosis (DVT) is responsible for 200,000 fatalities each year in the United States. Yet, according to the results of a recent study conducted by Premier Inc. and researchers from the University of California, Irvine, hospitals aren't doing such a great job of protecting patients from dangerous blood clots that form in veins.
Asheville asthma project outcomes positive
April 10th 2006Patients in the Asheville Project for asthma had improved outcomes over five years, including fewer ER visits and hospitalizations, according to researchers. In addition to better clinical outcomes through pharmacist interventions, annual direct cost savings averaged $725 per patient and annual indirect cost savings were estimated at $1,230 per patient, including less absenteeism.
Pharmacy First buys PBM and contract administrator
April 10th 2006Pharmacy First, a Nanuet, N.Y., firm giving a network of 3,500 independent pharmacies and regional chain drugstores access to manufacturer-sponsored programs, has acquired the PBM Beyond Rx and Third Party Station, a third-party contract administrator.
Changing or adding meds is key in refractory depression
April 10th 2006Level 2 results of the National Institute of Mental Health's STAR*D trial show that 25% of patients who switched to a new antidepressant after having no response to the SSRI citalopram in Level 1 became symptom-free within 14 weeks. Of the 1,439 patients studied, 727 were switched to sertraline (Zoloft, Pfizer), bupropion-SR, or venlafaxine-XR (Effexor-XR, Wyeth) and the improvement of depression was similar for each of the three drugs.
Second FDA group advises against ADHD warnings
April 10th 2006After reviewing data on ADHD drugs and their propensity to cause psychosis, mania, aggression, or cardiovascular side effects in children, the FDA's Pediatric Advisory Committee told the agency that black box warnings are not necessary, but rather warnings should be rewritten in a language that is better understood. This decision follows a recommendation in February from the agency's Drug Safety & Risk Management Advisory Committee to add the strongest possible warning regarding cardiovascular risk.
FTC to study authorized generics
April 10th 2006The Federal Trade Commission plans to investigate the likely short- and long-term competitive effects of authorized generic versions of brand drugs. FTC staffers have been authorized to subpoena about 80 drug companies, 10 authorized generic companies, and 100 independent generic manufacturers.